Neuroradiologic Features in X-linked α-Thalassemia/Mental Retardation Syndrome

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.

From the Divisions of Neurology (T.W.), Genetics (K.E., K.K.), and Radiology (N.A.), Kanagawa Children's Medical Center, Yokohama, Japan; Department of Pediatrics (H.B.), Himeji Red Cross Hospital, Himeji, Japan; Department of Pediatrics (M.M.), Yanagawa Institute for Developmental Disabilities, Yanagawa, Japan; and Department of Molecular Medicine (N.O.), Osaka Medical Center and Research Institute for Maternal and Child Health, Osaka, Japan.